Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL
- PMID: 32488654
- DOI: 10.1007/s00464-020-07689-z
Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL
Abstract
Background: Endobiliary radiofrequency ablation (EB-RFA) has emerged as a palliative treatment for malignant biliary strictures (MBSs); however, concerns about complications related to thermal injury remain. In this study, we evaluated the efficacy and safety of EB-RFA with a novel catheter for MBS.
Methods: Patients with inoperable cancer causing MBS were randomly assigned to either the radiofrequency ablation (RFA) group or the non-RFA group. The RFA group underwent EB-RFA at the stricture site with a temperature-controlled catheter (ELRA™; STARmed Co., Goyang, Korea) followed by deployment of a self-expanding metal stent (SEMS). For the non-RFA group, only SEMS placement was performed. The duration of stent patency, overall survival (OS), and 30-day complication rate were evaluated. This trial was registered at ClinicalTrials.gov (number NCT02646514).
Results: A total of 48 patients were enrolled (24 in each group). During a median follow-up period of 135.0 days (RFA group) and 119.5 days (non-RFA group), the 90-day stent patency rate, median duration of stent patency, and median OS were not different between the groups (58.3% vs. 45.8% [P = 0.386], 132.0 days vs. 116.0 days [P = 0.440], and 244.0 days vs. 180.0 days [P = 0.281], respectively). In the RFA group, procedure-related complications including thermal injury-related complications, such as bile duct perforation or hemobilia, were not reported. The early complication (< 7 days) rates were not different between the groups (4.2% vs. 12.5%, P = 0.609), and there were no late complications (7-30 days) in both groups.
Conclusion: EB-RFA with a temperature-controlled catheter followed by SEMS placement for patients with inoperable MBS can be safe and feasible with acceptable biliary patency.
Keywords: Biliary stricture; Endobiliary; Malignant; Metal stent; Palliative; Radiofrequency ablation.
Similar articles
-
The safety of newly developed automatic temperature-controlled endobiliary radiofrequency ablation system for malignant biliary strictures: A prospective multicenter study.J Gastroenterol Hepatol. 2019 Aug;34(8):1454-1459. doi: 10.1111/jgh.14657. Epub 2019 Apr 14. J Gastroenterol Hepatol. 2019. PMID: 30861593 Clinical Trial.
-
Adjuvant endobiliary radio-frequency ablation combined with self-expandable biliary metal stents for unresectable malignant hilar strictures: A pragmatic comparative study.Indian J Gastroenterol. 2025 Feb;44(1):72-79. doi: 10.1007/s12664-024-01668-1. Epub 2024 Sep 6. Indian J Gastroenterol. 2025. PMID: 39240508 Clinical Trial.
-
Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients.Surg Endosc. 2022 Mar;36(3):1789-1798. doi: 10.1007/s00464-021-08457-3. Epub 2021 Mar 31. Surg Endosc. 2022. PMID: 33788032
-
Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2023 Jun 1;35(6):646-653. doi: 10.1097/MEG.0000000000002568. Epub 2023 Apr 25. Eur J Gastroenterol Hepatol. 2023. PMID: 37129575
-
Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures: A Systematic Review and Meta-analysis.J Clin Gastroenterol. 2023 Apr 1;57(4):335-345. doi: 10.1097/MCG.0000000000001810. J Clin Gastroenterol. 2023. PMID: 36628465 Free PMC article.
Cited by
-
The effect of percutaneous endobiliary radiofrequency ablation on biliary stent patency.Sci Prog. 2025 Apr-Jun;108(2):368504251356422. doi: 10.1177/00368504251356422. Epub 2025 Jun 30. Sci Prog. 2025. PMID: 40586160 Free PMC article.
-
Silver Nanofunctionalized Stent after Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth.Pharmaceutics. 2022 Feb 14;14(2):412. doi: 10.3390/pharmaceutics14020412. Pharmaceutics. 2022. PMID: 35214144 Free PMC article.
-
Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials.Surg Endosc. 2022 Aug;36(8):5559-5570. doi: 10.1007/s00464-022-09181-2. Epub 2022 Mar 16. Surg Endosc. 2022. PMID: 35296949 Review.
-
Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis.Endosc Int Open. 2024 Jan 5;12(1):E23-E33. doi: 10.1055/a-2204-8316. eCollection 2024 Jan. Endosc Int Open. 2024. PMID: 38188927 Free PMC article. Review.
-
Endoscopic intraductal radiofrequency ablation for extrahepatic cholangiocarcinoma: An update (2023).World J Gastrointest Endosc. 2023 Jun 16;15(6):440-446. doi: 10.4253/wjge.v15.i6.440. World J Gastrointest Endosc. 2023. PMID: 37397976 Free PMC article. Review.
References
-
- Abraham NS, Barkun JS, Barkun AN (2002) Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 56(6):835–841 - DOI
-
- Rustagi T, Jamidar PA (2015) Endoscopic treatment of malignant biliary strictures. Curr Gastroenterol Rep 17(1):426 - PubMed
-
- Sawas T, Al Halabi S, Parsi MA, Vargo JJ (2015) Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 82(2):256–267.e257 - DOI
-
- Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K (1992) Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340(8834–8835):1488–1492 - DOI
-
- Cho JH, Jeong S, Kim EJ, Kim JM, Kim YS, Lee DH (2018) Long-term results of temperature-controlled endobiliary radiofrequency ablation in a normal swine model. Gastrointest Endosc 87(4):1147–1150 - DOI
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical